Literature DB >> 11941379

Confounding by indication in epidemiologic studies of commonly used analgesics.

Lisa B Signorello1, Joseph K McLaughlin, Loren Lipworth, Søren Friis, Henrik Toft Sørensen, William J Blot.   

Abstract

Confounding by indication is a bias frequently encountered in observational epidemiologic studies of drug effects. Because the allocation of treatment in observational studies is not randomized and the indication for treatment may be related to the risk of future health outcomes, the resulting imbalance in the underlying risk profile between treated and comparison groups can generate biased results. Confounding by indication is often present in studies of drugs that are not widely prescribed, because the indications for their use are narrow and not likely to be present in comparison groups; however, this bias is also observed in the study of widely used over-the-counter and prescription drugs, are exemplified by studies of analgesics. In this article we review examples from the published literature to demonstrate how confounding by indication can affect the findings of pharmacoepidemiologic studies relating analgesic use to various health outcomes.

Mesh:

Substances:

Year:  2002        PMID: 11941379     DOI: 10.1097/00045391-200205000-00005

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  59 in total

1.  Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.

Authors:  Michael C Irizarry; David J Webb; Nada Boudiaf; John Logie; Laurel A Habel; Natalia Udaltsova; Gary D Friedman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-12-06       Impact factor: 2.890

2.  A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin.

Authors:  David N Juurlink; Muhammad M Mamdani; Alexander Kopp; Nathan Herrmann; Andreas Laupacis
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

3.  Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Authors:  L A García Rodríguez; J Lagergren; M Lindblad
Journal:  Gut       Date:  2006-06-19       Impact factor: 23.059

4.  A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort.

Authors:  Marcus Osterbrand; Martin Fahlén; Anders Odén; Björn Eliasson
Journal:  Eur J Epidemiol       Date:  2007-02-06       Impact factor: 8.082

5.  Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash.

Authors:  Ryan N Hansen; Denise M Boudreau; Beth E Ebel; David C Grossman; Sean D Sullivan
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

6.  Vitamin D and health-related quality of life in a community sample of older Canadians.

Authors:  Y S Chao; J P Ekwaru; A Ohinmaa; G Griener; P J Veugelers
Journal:  Qual Life Res       Date:  2014-04-24       Impact factor: 4.147

7.  Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.

Authors:  Craig S Wong; Christopher B Pierce; Stephen R Cole; Bradley A Warady; Robert H K Mak; Nadine M Benador; Fredrick Kaskel; Susan L Furth; George J Schwartz
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 8.237

8.  Impaired visual fixation at the age of 2 years in children born before the twenty-eighth week of gestation. Antecedents and correlates in the multicenter ELGAN study.

Authors:  Anuradha Phadke; Michael E Msall; Patrick Droste; Elizabeth N Allred; Thomas Michael O'Shea; Karl Kuban; Olaf Dammann; Alan Leviton
Journal:  Pediatr Neurol       Date:  2014-03-15       Impact factor: 3.372

9.  The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study.

Authors:  Charmaine A Cooke; Susan A Kirkland; Ingrid S Sketris; Jafna Cox
Journal:  BMC Health Serv Res       Date:  2009-11-04       Impact factor: 2.655

10.  The ELGAN study of the brain and related disorders in extremely low gestational age newborns.

Authors:  T M O'Shea; E N Allred; O Dammann; D Hirtz; K C K Kuban; N Paneth; A Leviton
Journal:  Early Hum Dev       Date:  2009-09-17       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.